세계의 곰팡이성 족부질환 치료제 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Fungal Foot-Animal was estimated to be worth US$ 1291 million in 2024 and is forecast to a readjusted size of US$ 1761 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fungal Foot-Animal cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Fungal foot-animal, known medically as tinea pedis, is a common skin infection of the feet caused by fungus. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. In this report, we study the drugs for Fungal foot-animal.

The fungal foot infection treatment market for animals is driven by the increasing awareness of animal health and welfare, especially in livestock and companion animals. Rising demand for animal-based products, such as dairy, meat, and poultry, has made proper animal hygiene and disease prevention a top priority for farmers and veterinary professionals. Additionally, the expansion of pet ownership and higher spending on pet healthcare globally are fueling demand for antifungal products, including topical ointments, sprays, and veterinary prescription treatments.

A major challenge in this market is the limited availability of species-specific antifungal treatments, particularly for large-scale livestock applications. In many regions, farmers may rely on generalized or off-label products due to cost concerns or lack of veterinary infrastructure. Moreover, fungal resistance and recurrence remain persistent issues, requiring combination therapies and longer treatment durations. Compliance with veterinary drug regulations, especially concerning drug residues in food-producing animals, further complicates product development and approval for manufacturers.

This report aims to provide a comprehensive presentation of the global market for Fungal Foot-Animal, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fungal Foot-Animal by region & country, by Type, and by Application.

The Fungal Foot-Animal market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Foot-Animal.

Market Segmentation

By Company

• Bayer
• GSK
• Johnson & Johnson
• Novartis
• Bausch Health
• TEVA
• Taro Pharmaceutical
• WellSpring Pharma
• Crown Laboratories
• Medimetriks Pharmaceuticals
• Kaken Pharmaceutical
• Padagis
• Gufic Biosciences
• Jingwei Pharma
• Jiangsu Zhiyuan Pharma

Segment by Type

• Cream
• Spray
• Other

Segment by Application

• Offline Store
• Online Store

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fungal Foot-Animal manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Fungal Foot-Animal in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Fungal Foot-Animal in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Fungal Foot-Animal Product Introduction
• 1.2 Global Fungal Foot-Animal Market Size Forecast
  • 1.2.1 Global Fungal Foot-Animal Sales Value (2020-2031)
  • 1.2.2 Global Fungal Foot-Animal Sales Volume (2020-2031)
  • 1.2.3 Global Fungal Foot-Animal Sales Price (2020-2031)
• 1.3 Fungal Foot-Animal Market Trends & Drivers
  • 1.3.1 Fungal Foot-Animal Industry Trends
  • 1.3.2 Fungal Foot-Animal Market Drivers & Opportunity
  • 1.3.3 Fungal Foot-Animal Market Challenges
  • 1.3.4 Fungal Foot-Animal Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Fungal Foot-Animal Players Revenue Ranking (2024)
• 2.2 Global Fungal Foot-Animal Revenue by Company (2020-2025)
• 2.3 Global Fungal Foot-Animal Players Sales Volume Ranking (2024)
• 2.4 Global Fungal Foot-Animal Sales Volume by Company Players (2020-2025)
• 2.5 Global Fungal Foot-Animal Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Fungal Foot-Animal Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Fungal Foot-Animal Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Fungal Foot-Animal
• 2.9 Fungal Foot-Animal Market Competitive Analysis
  • 2.9.1 Fungal Foot-Animal Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Fungal Foot-Animal Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Foot-Animal as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Cream
  • 3.1.2 Spray
  • 3.1.3 Other
• 3.2 Global Fungal Foot-Animal Sales Value by Type
  • 3.2.1 Global Fungal Foot-Animal Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Fungal Foot-Animal Sales Value, by Type (2020-2031)
  • 3.2.3 Global Fungal Foot-Animal Sales Value, by Type (%) (2020-2031)
• 3.3 Global Fungal Foot-Animal Sales Volume by Type
  • 3.3.1 Global Fungal Foot-Animal Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Fungal Foot-Animal Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Fungal Foot-Animal Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Fungal Foot-Animal Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Offline Store
  • 4.1.2 Online Store
• 4.2 Global Fungal Foot-Animal Sales Value by Application
  • 4.2.1 Global Fungal Foot-Animal Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Fungal Foot-Animal Sales Value, by Application (2020-2031)
  • 4.2.3 Global Fungal Foot-Animal Sales Value, by Application (%) (2020-2031)
• 4.3 Global Fungal Foot-Animal Sales Volume by Application
  • 4.3.1 Global Fungal Foot-Animal Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Fungal Foot-Animal Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Fungal Foot-Animal Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Fungal Foot-Animal Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Fungal Foot-Animal Sales Value by Region
  • 5.1.1 Global Fungal Foot-Animal Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Fungal Foot-Animal Sales Value by Region (2020-2025)
  • 5.1.3 Global Fungal Foot-Animal Sales Value by Region (2026-2031)
  • 5.1.4 Global Fungal Foot-Animal Sales Value by Region (%), (2020-2031)
• 5.2 Global Fungal Foot-Animal Sales Volume by Region
  • 5.2.1 Global Fungal Foot-Animal Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Fungal Foot-Animal Sales Volume by Region (2020-2025)
  • 5.2.3 Global Fungal Foot-Animal Sales Volume by Region (2026-2031)
  • 5.2.4 Global Fungal Foot-Animal Sales Volume by Region (%), (2020-2031)
• 5.3 Global Fungal Foot-Animal Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Fungal Foot-Animal Sales Value, 2020-2031
  • 5.4.2 North America Fungal Foot-Animal Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Fungal Foot-Animal Sales Value, 2020-2031
  • 5.5.2 Europe Fungal Foot-Animal Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Fungal Foot-Animal Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Fungal Foot-Animal Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Fungal Foot-Animal Sales Value, 2020-2031
  • 5.7.2 South America Fungal Foot-Animal Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Fungal Foot-Animal Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Fungal Foot-Animal Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Fungal Foot-Animal Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Fungal Foot-Animal Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Fungal Foot-Animal Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Fungal Foot-Animal Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Fungal Foot-Animal Sales Value, 2020-2031
  • 6.3.2 United States Fungal Foot-Animal Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Fungal Foot-Animal Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Fungal Foot-Animal Sales Value, 2020-2031
  • 6.4.2 Europe Fungal Foot-Animal Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Fungal Foot-Animal Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Fungal Foot-Animal Sales Value, 2020-2031
  • 6.5.2 China Fungal Foot-Animal Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Fungal Foot-Animal Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Fungal Foot-Animal Sales Value, 2020-2031
  • 6.6.2 Japan Fungal Foot-Animal Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Fungal Foot-Animal Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Fungal Foot-Animal Sales Value, 2020-2031
  • 6.7.2 South Korea Fungal Foot-Animal Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Fungal Foot-Animal Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Fungal Foot-Animal Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Fungal Foot-Animal Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Fungal Foot-Animal Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Fungal Foot-Animal Sales Value, 2020-2031
  • 6.9.2 India Fungal Foot-Animal Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Fungal Foot-Animal Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Bayer
  • 7.1.1 Bayer Company Information
  • 7.1.2 Bayer Introduction and Business Overview
  • 7.1.3 Bayer Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Bayer Fungal Foot-Animal Product Offerings
  • 7.1.5 Bayer Recent Development
• 7.2 GSK
  • 7.2.1 GSK Company Information
  • 7.2.2 GSK Introduction and Business Overview
  • 7.2.3 GSK Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 GSK Fungal Foot-Animal Product Offerings
  • 7.2.5 GSK Recent Development
• 7.3 Johnson & Johnson
  • 7.3.1 Johnson & Johnson Company Information
  • 7.3.2 Johnson & Johnson Introduction and Business Overview
  • 7.3.3 Johnson & Johnson Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Johnson & Johnson Fungal Foot-Animal Product Offerings
  • 7.3.5 Johnson & Johnson Recent Development
• 7.4 Novartis
  • 7.4.1 Novartis Company Information
  • 7.4.2 Novartis Introduction and Business Overview
  • 7.4.3 Novartis Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Novartis Fungal Foot-Animal Product Offerings
  • 7.4.5 Novartis Recent Development
• 7.5 Bausch Health
  • 7.5.1 Bausch Health Company Information
  • 7.5.2 Bausch Health Introduction and Business Overview
  • 7.5.3 Bausch Health Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Bausch Health Fungal Foot-Animal Product Offerings
  • 7.5.5 Bausch Health Recent Development
• 7.6 TEVA
  • 7.6.1 TEVA Company Information
  • 7.6.2 TEVA Introduction and Business Overview
  • 7.6.3 TEVA Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 TEVA Fungal Foot-Animal Product Offerings
  • 7.6.5 TEVA Recent Development
• 7.7 Taro Pharmaceutical
  • 7.7.1 Taro Pharmaceutical Company Information
  • 7.7.2 Taro Pharmaceutical Introduction and Business Overview
  • 7.7.3 Taro Pharmaceutical Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Taro Pharmaceutical Fungal Foot-Animal Product Offerings
  • 7.7.5 Taro Pharmaceutical Recent Development
• 7.8 WellSpring Pharma
  • 7.8.1 WellSpring Pharma Company Information
  • 7.8.2 WellSpring Pharma Introduction and Business Overview
  • 7.8.3 WellSpring Pharma Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 WellSpring Pharma Fungal Foot-Animal Product Offerings
  • 7.8.5 WellSpring Pharma Recent Development
• 7.9 Crown Laboratories
  • 7.9.1 Crown Laboratories Company Information
  • 7.9.2 Crown Laboratories Introduction and Business Overview
  • 7.9.3 Crown Laboratories Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Crown Laboratories Fungal Foot-Animal Product Offerings
  • 7.9.5 Crown Laboratories Recent Development
• 7.10 Medimetriks Pharmaceuticals
  • 7.10.1 Medimetriks Pharmaceuticals Company Information
  • 7.10.2 Medimetriks Pharmaceuticals Introduction and Business Overview
  • 7.10.3 Medimetriks Pharmaceuticals Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Medimetriks Pharmaceuticals Fungal Foot-Animal Product Offerings
  • 7.10.5 Medimetriks Pharmaceuticals Recent Development
• 7.11 Kaken Pharmaceutical
  • 7.11.1 Kaken Pharmaceutical Company Information
  • 7.11.2 Kaken Pharmaceutical Introduction and Business Overview
  • 7.11.3 Kaken Pharmaceutical Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Kaken Pharmaceutical Fungal Foot-Animal Product Offerings
  • 7.11.5 Kaken Pharmaceutical Recent Development
• 7.12 Padagis
  • 7.12.1 Padagis Company Information
  • 7.12.2 Padagis Introduction and Business Overview
  • 7.12.3 Padagis Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Padagis Fungal Foot-Animal Product Offerings
  • 7.12.5 Padagis Recent Development
• 7.13 Gufic Biosciences
  • 7.13.1 Gufic Biosciences Company Information
  • 7.13.2 Gufic Biosciences Introduction and Business Overview
  • 7.13.3 Gufic Biosciences Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Gufic Biosciences Fungal Foot-Animal Product Offerings
  • 7.13.5 Gufic Biosciences Recent Development
• 7.14 Jingwei Pharma
  • 7.14.1 Jingwei Pharma Company Information
  • 7.14.2 Jingwei Pharma Introduction and Business Overview
  • 7.14.3 Jingwei Pharma Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Jingwei Pharma Fungal Foot-Animal Product Offerings
  • 7.14.5 Jingwei Pharma Recent Development
• 7.15 Jiangsu Zhiyuan Pharma
  • 7.15.1 Jiangsu Zhiyuan Pharma Company Information
  • 7.15.2 Jiangsu Zhiyuan Pharma Introduction and Business Overview
  • 7.15.3 Jiangsu Zhiyuan Pharma Fungal Foot-Animal Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Jiangsu Zhiyuan Pharma Fungal Foot-Animal Product Offerings
  • 7.15.5 Jiangsu Zhiyuan Pharma Recent Development

8 Industry Chain Analysis

• 8.1 Fungal Foot-Animal Industrial Chain
• 8.2 Fungal Foot-Animal Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Fungal Foot-Animal Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Fungal Foot-Animal Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer